The Journal of Immunology, Vol 138, Issue 2 358-363, Copyright © 1987 by American Association of Immunologists

ARTICLES

Thymocyte binding to human thymic epithelial cells is inhibited by monoclonal antibodies to CD-2 and LFA-3 antigens

LW Vollger, DT Tuck, TA Springer, BF Haynes and KH Singer

With the use of cultured human thymic epithelial (TE) cells, we have previously shown that thymocytes bind to TE cells in suspension in a rosette-forming assay. To identify cell surface molecules involved in human TE-thymocyte rosette formation, we assayed a large panel of monoclonal antibodies for their ability to inhibit rosette formation. We found anti-CD-2 (LFA-2, T11), and anti-LFA-3 antibodies all inhibited binding of TE cells to thymocytes. By using indirect immunofluorescence assays, we determined that cultured TE cells were 90% LFA-3 positive and CD-2 negative, whereas thymocytes were 10% LFA-3 positive and 98% CD-2 positive. Pretreatment of TE cells with anti-LFA- 3 but not anti-LFA-2 inhibited TE-thymocyte binding. In contrast, pretreatment of thymocytes with anti-CD-2 but not anti-LFA-3 antibodies inhibited TE-thymocyte binding. Thus TE cell-thymocyte binding is blocked by antibodies to the CD-2 (T11) antigen on thymocytes and by an antibody to the LFA-3 antigen on TE cells. Because the CD-2 antigen has been implicated in T cell activation, these data suggest that a natural ligand for T cell activation via the CD-2 molecule is present on human thymic epithelial cells.

This article has been cited by other articles:

				D.-M. Zhu, M. L. Dustin, C. W. Cairo, and D. E. Golan Analysis of Two-Dimensional Dissociation Constant of Laterally Mobile Cell Adhesion Molecules Biophys. J., February 1, 2007; 92(3): 1022 - 1034. [Abstract] [Full Text] [PDF]

				Y. Kato, Y. Tanaka, M. Hayashi, K. Okawa, and N. Minato Involvement of CD166 in the Activation of Human {gamma}{delta}T Cells by Tumor Cells Sensitized with Nonpeptide Antigens J. Immunol., July 15, 2006; 177(2): 877 - 884. [Abstract] [Full Text] [PDF]

				N. G. Singer, D. A. Fox, T. M. Haqqi, L. Beretta, J. S. Endres, S. Prohaska, J. R. Parnes, J. Bromberg, and R. M. Sramkoski CD6: expression during development, apoptosis and selection of human and mouse thymocytes Int. Immunol., June 1, 2002; 14(6): 585 - 597. [Abstract] [Full Text] [PDF]

				W. Savino and M. Dardenne Neuroendocrine Control of Thymus Physiology Endocr. Rev., August 1, 2000; 21(4): 412 - 443. [Abstract] [Full Text] [PDF]

				M. Rothe, L. Chene, M.-T. Nugeyre, J. Braun, F. Barre-Sinoussi, and N. Israel Contact with Thymic Epithelial Cells as a Prerequisite for Cytokine-Enhanced Human Immunodeficiency Virus Type 1 Replication in Thymocytes J. Virol., July 1, 1998; 72(7): 5852 - 5861. [Abstract] [Full Text] [PDF]

				C. Dumont, O. Deas, B. Mollereau, C. Hebib, V. Giovino-Barry, A. Bernard, F. Hirsch, B. Charpentier, and A. Senik Potent Apoptotic Signaling and Subsequent Unresponsiveness Induced by a Single CD2 mAb (BTI-322) in Activated Human Peripheral T Cells J. Immunol., April 15, 1998; 160(8): 3797 - 3804. [Abstract] [Full Text] [PDF]

				S.-J. Teh, N. Killeen, A. Tarakhovsky, D. R. Littman, and H.-S. Teh CD2 Regulates the Positive Selection and Function of Antigen-Specific CD4-CD8+ T Cells Blood, February 15, 1997; 89(4): 1308 - 1318. [Abstract] [Full Text] [PDF]

				R. H.H. Pieters, M. Bol, W. Seinen, and A. H. Penninks Cellular and molecular aspects of organotin-induced thymus atrophy Human and Experimental Toxicology, January 1, 1994; 13(12): 876 - 879. [Abstract] [PDF]

				W. Hahn, E Menu, A. Bothwell, P. Sims, and B. Bierer Overlapping but nonidentical binding sites on CD2 for CD58 and a second ligand CD59 Science, June 26, 1992; 256(5065): 1805 - 1807. [Abstract] [PDF]

				M.H. Brown, E. Monostori, M. Gullberg, R. Zamoyska, G. Lang, D. Kioussis, and M.J. Crumpton Structure-Function Relationships of the Human T Lymphocyte CD2 Antigen Cold Spring Harb Symp Quant Biol, January 1, 1989; 54(0): 627 - 636. [Abstract] [PDF]